DAFNA Capital Management as of Sept. 30, 2018
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 75 positions in its portfolio as reported in the September 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Loxo Oncology | 11.9 | $29M | 170k | 170.83 | |
Stereotaxis (STXS) | 6.8 | $17M | 14M | 1.21 | |
Sage Therapeutics (SAGE) | 5.8 | $14M | 99k | 141.25 | |
AtriCure (ATRC) | 4.2 | $10M | 294k | 35.03 | |
NxStage Medical | 3.5 | $8.5M | 306k | 27.89 | |
Aerie Pharmaceuticals | 3.4 | $8.2M | 133k | 61.55 | |
Blueprint Medicines (BPMC) | 3.0 | $7.2M | 93k | 78.06 | |
Zogenix | 2.8 | $6.9M | 138k | 49.60 | |
Alder Biopharmaceuticals | 2.7 | $6.6M | 396k | 16.65 | |
Akebia Therapeutics (AKBA) | 2.3 | $5.5M | 626k | 8.83 | |
Ascendis Pharma A S (ASND) | 2.2 | $5.5M | 77k | 70.86 | |
Dex (DXCM) | 2.2 | $5.3M | 37k | 143.03 | |
Neurocrine Biosciences (NBIX) | 2.1 | $5.0M | 41k | 122.95 | |
Proqr Thrapeutics N V shs euro (PRQR) | 2.1 | $5.0M | 260k | 19.35 | |
BioCryst Pharmaceuticals (BCRX) | 2.0 | $5.0M | 652k | 7.63 | |
Argenx Se (ARGX) | 2.0 | $4.9M | 64k | 75.85 | |
Foamix Pharmaceuticals | 1.9 | $4.6M | 808k | 5.73 | |
Arena Pharmaceuticals | 1.9 | $4.5M | 99k | 46.02 | |
Galapagos Nv- (GLPG) | 1.8 | $4.5M | 40k | 112.42 | |
Kura Oncology (KURA) | 1.7 | $4.2M | 241k | 17.50 | |
Luminex Corporation | 1.7 | $4.2M | 138k | 30.31 | |
Immunomedics | 1.5 | $3.7M | 178k | 20.83 | |
Cymabay Therapeutics | 1.3 | $3.3M | 295k | 11.08 | |
iShares NASDAQ Biotechnology Index (IBB) | 1.3 | $3.2M | 26k | 121.95 | |
Xenon Pharmaceuticals (XENE) | 1.3 | $3.1M | 238k | 13.20 | |
Achillion Pharmaceuticals | 1.3 | $3.1M | 848k | 3.68 | |
Radius Health Inc note 3.000% 9/0 | 1.3 | $3.1M | 4.0M | 0.77 | |
Menlo Therapeutics | 1.3 | $3.1M | 312k | 9.85 | |
Intec Pharma | 1.2 | $3.0M | 537k | 5.65 | |
Biotelemetry | 1.2 | $3.0M | 47k | 64.44 | |
Bluebird Bio (BLUE) | 1.2 | $3.0M | 21k | 146.00 | |
Cara Therapeutics (CARA) | 1.1 | $2.7M | 113k | 23.95 | |
Applied Genetic Technol Corp C | 1.1 | $2.6M | 360k | 7.30 | |
ArQule | 1.0 | $2.5M | 448k | 5.66 | |
Wave Life Sciences (WVE) | 1.0 | $2.4M | 48k | 50.00 | |
Vbi Vaccines | 0.9 | $2.3M | 935k | 2.42 | |
Cardiovascular Systems | 0.9 | $2.2M | 56k | 39.15 | |
Ardelyx (ARDX) | 0.8 | $2.1M | 473k | 4.35 | |
Insulet Corp note 1.375% | 0.8 | $1.9M | 1.5M | 1.27 | |
Dicerna Pharmaceuticals | 0.7 | $1.8M | 119k | 15.26 | |
Macrogenics (MGNX) | 0.7 | $1.7M | 78k | 21.44 | |
Advaxis | 0.6 | $1.6M | 1.7M | 0.94 | |
Scynexis | 0.6 | $1.5M | 1.3M | 1.20 | |
Translate Bio | 0.6 | $1.5M | 152k | 10.00 | |
Incyte Corporation (INCY) | 0.6 | $1.5M | 22k | 69.07 | |
Natus Medical | 0.6 | $1.4M | 38k | 35.65 | |
Novavax | 0.5 | $1.3M | 700k | 1.88 | |
Johnson & Johnson (JNJ) | 0.5 | $1.3M | 9.4k | 138.19 | |
Immune Design | 0.5 | $1.1M | 329k | 3.45 | |
Biohaven Pharmaceutical Holding | 0.5 | $1.1M | 30k | 37.57 | |
Leap Therapeutics | 0.5 | $1.1M | 141k | 7.79 | |
Zafgen | 0.4 | $1.0M | 86k | 11.68 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.4 | $936k | 213k | 4.40 | |
Obseva Sa | 0.3 | $781k | 43k | 18.02 | |
Sunesis Pharmaceuticals Inc Ne | 0.3 | $747k | 374k | 2.00 | |
Spero Therapeutics (SPRO) | 0.3 | $736k | 70k | 10.51 | |
Urogen Pharma (URGN) | 0.3 | $708k | 15k | 47.20 | |
Cytokinetics (CYTK) | 0.2 | $617k | 63k | 9.84 | |
Rigel Pharmaceuticals | 0.2 | $442k | 138k | 3.21 | |
Neon Therapeutics | 0.2 | $427k | 50k | 8.54 | |
Aptinyx | 0.2 | $420k | 15k | 28.97 | |
Sutro Biopharma (STRO) | 0.2 | $412k | 28k | 14.99 | |
Assembly Biosciences | 0.2 | $396k | 11k | 37.10 | |
Kalvista Pharmaceuticals (KALV) | 0.2 | $392k | 18k | 22.12 | |
Dexcom Inc dbcv 0.750% 5/1 | 0.2 | $383k | 250k | 1.53 | |
Masimo Corporation (MASI) | 0.1 | $374k | 3.0k | 124.67 | |
Radius Health | 0.1 | $365k | 21k | 17.80 | |
Minerva Neurosciences | 0.1 | $338k | 27k | 12.56 | |
Alder Biopharmaceuticals Inc convertible security | 0.1 | $270k | 250k | 1.08 | |
Sol Gel Technologies (SLGL) | 0.1 | $263k | 35k | 7.51 | |
BioTime | 0.1 | $235k | 100k | 2.35 | |
Kadmon Hldgs | 0.1 | $210k | 63k | 3.33 | |
Bellicum Pharma | 0.1 | $185k | 30k | 6.17 | |
Neos Therapeutics | 0.1 | $133k | 28k | 4.84 | |
Dermira | 0.0 | $55k | 5.0k | 11.00 |